x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Decera Clinical Education Infectious Disease Podcast

Decera Clinical Education

Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Decera Clinical Education. Gain practical strategies and earn CME/CE credit for selected episodes.

education courses

All Episodes

00:40:10

Q&A: HDV Management Episode 2

Decera Clinical Education Infectious Disease Podcast ·

2023/04/26

In this episode, Tatyana Kushner, MD, MSCE, and Stefan Zeuzem, MD, address key considerations when screening, diagnosing, and treating patients with HDV, such as:Barriers to HDV screening, including limitations to AASLD guideline recommendationsUse of double reflex testing to improve HDV diagnosisConsiderations for repeat HDV testing in patients who are HBsAg positive who previously tested negative for HDVUpdated CDC recommendations for HBV screening for all adults using a triple panel test Staging

en

00:52:07

Overcoming HBV Barriers: Focus on Asian American People

Decera Clinical Education Infectious Disease Podcast ·

2023/04/25

In this episode, Joseph Lim, MD; Mindie H. Nguyen, MD, MAS, AGAF, FAASLD; and Jennifer Wild, MS, BSN, RN, OCN, discuss strategies for overcoming barriers to HBV care in Asian American people, including:HBV-related stigmaLanguage barriersHealth insurance navigationPresenters:Joseph Lim, MDProfessor of Medicine Director, Clinical HepatologyVice-Chief, Section of Digestive DiseasesYale University School of MedicineNew Haven, Connecticut Mindie H. Nguyen, MD, MAS, AGAF, FAASLDProfessor of Medicine (GI &

en

00:58:49

African Immigrant People: Overcoming HBV Barriers

Decera Clinical Education Infectious Disease Podcast ·

2023/04/25

In this episode, Essa Mohamed, PhD; Daouda Ndiaye; and Ponni Perumalswami, MD, MS, discuss strategies for overcoming barriers to HBV care in African immigrant people, including:HBV awareness and misconceptionsHBV-related stigmaLanguage barriersHealth insurance navigationPresenters: Essa Mohamed, PhDClinical ResearcherDivision of Gastroenterology and HepatologyMayo ClinicRochester, MinnesotaDaouda NdiayePatient NavigatorPonni Perumalswami, MD, MSAssociate Professor of Internal MedicineDivision of

en

00:05:36

Individualizing HIV ART: Considerations for Weight Gain

Decera Clinical Education Infectious Disease Podcast ·

2023/04/24

In this episode, Daniel R. Kuritzkes, MD, discusses considerations for patients experiencing weight gain on antiretroviral therapy, including:• Commonly implicated antiretroviral therapy regimens and patient populations• Guideline recommendations for management of weight gainPresenter:Daniel R. Kuritzkes, MDHarriet Ryan Albee Professor of MedicineHarvard Medical SchoolChief, Division of Infectious DiseasesBrigham and Women’s HospitalBoston, MassachusettsTo download the slides: bit.ly/3odUA9CTo view

en

00:49:13

Rapid ART Initiation: Answering the Questions

Decera Clinical Education Infectious Disease Podcast ·

2023/04/21

In this episode, Isolde Butler, MD, and Brenda E. Crabtree Ramírez, MD, discuss rapid ART initiation for people newly diagnosed with HIV, including:The HIV care continuum in the United States and Latin AmericaBarriers to HIV diagnosis, including stigma, discriminatory laws and policies, social determinants of health, and lack of access to healthcareFactors that predict delayed care linkage and inconsistent HIV care and treatmentImproved clinical outcomes that have been shown with rapid ART

en

00:04:28

Individualizing HIV ART: Rapid Start

Decera Clinical Education Infectious Disease Podcast ·

2023/04/13

In this episode, Daniel R. Kuritzkes, MD, discusses considerations for rapid initiation of antiretroviral therapy in patients who are newly diagnosed with HIV, including:Recommended regimensManagement of patients previously receiving PrEPTiming of laboratory testingPresenter:Daniel R. Kuritzkes, MDHarriet Ryan Albee Professor of MedicineHarvard Medical SchoolChief, Division of Infectious DiseasesBrigham and Women’s HospitalBoston, MassachusettsTo download the slides: https://bit.ly/3odUA9CTo view

en

00:21:38

Perspectives From Asia on Advances in HIV Treatment...

Decera Clinical Education Infectious Disease Podcast ·

2023/03/27

In this episode, 2 HIV experts from the Asia-Pacific region share their thoughts on some of the most important new insights from HIV treatment and prevention research over the past year.Specifically, the faculty discuss the role of newer innovations in HIV, including 2-drug oral antiretroviral therapy (ART) regimens, 2-drug long-acting injectable ART, and long-acting HIV pre-exposure prophylaxis in HIV care in the Asia-Pacific region, as well as the implications of weight gain with ART and important

en

00:12:24

RSV in Adults: How It Presents

Decera Clinical Education Infectious Disease Podcast ·

2023/03/22

In this episode, Angela Branche, MD, and Helen Y. Chu, MD, MPH, discuss the clinical presentation of respiratory syncytial virus (RSV) in adults and the importance of early detection, including: Clinical symptoms and presentation Complications, including exacerbations of cardiopulmonary diseasesUse of medical resources compared with other respiratory virusesDiagnostic approaches and challengesTreatment and management of RSV diseaseClinical impact of RSV awarenessFaculty: Angela Branche,

en

00:10:43

RSV in Adults: A Hidden Epidemic

Decera Clinical Education Infectious Disease Podcast ·

2023/03/22

In this episode, Angela Branche, MD, and Helen Y. Chu, MD, MPH, discuss the impact of respiratory syncytial virus (RSV) and describe those at risk for severe RSV disease, including: RSV prevalence and seasonality RSV burden throughout life, including burden in older adultsComorbidities that increase the risk of RSV complications RSV transmission in the hospital and care home settingImplications of risk factors for severe RSV on prevention and treatment Faculty: Angela Branche, MDAssociate

en

00:37:40

Answering the Questions on Optimizing Antiretroviral...

Decera Clinical Education Infectious Disease Podcast ·

2023/03/21

In this episode, José R. Arribas, MD, and Melissa Badowski, PharmD, MPH, FIDSA, FCCP, BCIDP, BCPS, AAHIVP, discuss optimizing antiretroviral therapy (ART) for people with HIV who are treatment experienced or failing a current ART regimen, including:The use of proviral DNA genotyping for switching therapyMaintaining nucleos(t)ide reverse-transcriptase inhibitors after a first failureThe role of zidovudine in salvage regimensThe use of twice-daily darunavir with protease inhibitor resistance and

en

00:54:29

Answering the Questions on HIV PrEP Persistence

Decera Clinical Education Infectious Disease Podcast ·

2023/03/16

In this episode, Darrell H. S. Tan, MD, FRCPC, PhD, and Kenric Ware, PharmD, AAHIVP, discuss considerations for HIV pre-exposure prophylaxis (PrEP) persistence, including:The PrEP continuum of care in the United States, including inequities in PrEP uptake and persistence by raceCDC PrEP guidance regarding PrEP indicationsPrEP eligibility by regimenSummary of renal, bone, and weight outcomes with different PrEP optionsData on HIV acquisition following PrEP discontinuationDrug concentrations and

en

00:31:49

Answering Questions on Which HIV PrEP for Which...

Decera Clinical Education Infectious Disease Podcast ·

2023/03/15

In this episode, Carolyn Chu, MD, MSc, FAAFP, AAHIVS, and Samantha Strong, PharmD, BCACP, AAHIVP, CDCES, answer questions including:Strategies to improve disparities in pre-exposure prophylaxis (PrEP) access in difficult-to-reach populations Key remaining questions related to PrEP options for cisgender women and people who inject drugsConcerns about resistance at seroconversion in patients with suboptimal PrEP complianceImplementation of molecular screening for patients receiving PrEPExpectations

en

00:22:43

Hepatitis Delta in Focus: Episode 1 of Answering the...

Decera Clinical Education Infectious Disease Podcast ·

2023/03/08

In this episode, Maria Buti, MD, and Richard H. Davis, PA-C, address key considerations when screening, diagnosing, and treating patients with hepatitis delta virus (HDV), such as:Barriers to screening HDV screening based on patient risk factors Universal screening for all patients with positive hepatitis B surface antigen (HBsAg)Reflex testing Availability of commercial testingMonitoring suggestions in HBsAg positive and HDV antibody positive patients with negative HDV RNALimitations to evaluating

en

00:06:24

Barriers to HIV PrEP: Addressing Intersectionality

Decera Clinical Education Infectious Disease Podcast ·

2023/03/06

In this episode, Latesha Elopre, MD, MSPH, discusses key considerations to barriers to PrEP uptake, including:Addressing disparities among racial and ethnic minority populationsUnderstanding the concept of intersectionality Tackling multiple levels of intersectionalityIndividual (eg, self-stigma, mental health)Network (eg, access to PrEP services)Community (eg, racism, stigma, poverty)Social and structural (eg, laws/policies)Epidemic (eg, population level of viremia)Presenter: Latesha Elopre, MD,

en

00:05:51

Long-Acting ART: Lenacapavir

Decera Clinical Education Infectious Disease Podcast ·

2023/03/03

In this episode, Darcey Wooten, MD, discusses the long-acting HIV treatment agent lenacapavir for treatment-experienced people with HIV, including:Efficacy dataInitiation strategiesVirologic failure dataSafety informationPresenter:Darcy Wooten, MDAssociate Professor of MedicineDivision of Infectious Diseases and Global Public HealthDepartment of MedicineUniversity of California, San DiegoSan Diego, CaliforniaTo download the slides:http://bit.ly/3Jb1ofXTo view the full online

en

00:03:52

Long-Acting PrEP: Monitoring for New HIV Infection

Decera Clinical Education Infectious Disease Podcast ·

2023/03/03

In this episode, Darcey Wooten, MD, discusses updated guidance and rationale for monitoring for new HIV infections in people receiving long-acting PrEP, including:Testing both Ag/Ab and HIV-1 RNASteps to take when a person receiving long-acting PrEP develops a new HIV infectionPresenter:Darcy Wooten, MDAssociate Professor of MedicineDivision of Infectious Diseases and Global Public HealthDepartment of MedicineUniversity of California, San DiegoSan Diego, CaliforniaTo download the

en

00:25:44

Ensuring Linkage to Care for Patients Diagnosed With...

Decera Clinical Education Infectious Disease Podcast ·

2023/02/23

In this episode, Nancy Reau, MD, and Lydia Tang, MBChB, discuss how to increase linkage to care rates for persons with hepatitis D virus, including:Updates on currently low rates of linkage to careBarriers preventing patients with HBV/HDV coinfection from engaging in careInterventions to increase retention in care for patients with HDV Faculty: Nancy Reau, MDProfessor of MedicineChief, Section of Hepatology Associate Director, Solid Organ Transplantation Richard B. Capps Chair of HepatologyRush

en

00:14:56

How to Screen for Hepatitis Delta Virus

Decera Clinical Education Infectious Disease Podcast ·

2023/02/23

In this episode, Coleman I. Smith, MD, and Lydia Tang, MBChB, discuss how to screen for hepatitis delta virus (HDV), including:Algorithm for evaluation of HDVDiagnosis of different stages of HDV infection Strategies to increase HDV testing rates Faculty:Coleman I. Smith, MDProfessor of MedicineHepatologistGeorgetown Transplant InstituteGeorgetown UniversityWashington, DCLydia Tang, MBChB Assistant ProfessorDepartment of Infectious DiseasesUniversity of Maryland School of MedicineInstitute of Human

en

00:23:22

Questions Answered on ART Safety and Tolerability in...

Decera Clinical Education Infectious Disease Podcast ·

2023/02/23

In this episode, Jill Blumenthal, MD, MAS, and William R. Short, MD, MPH, AAHIVS, address key considerations when evaluating ART safety and tolerability in pregnant people, those trying to conceive, and transgender individuals, such as:Approaching patients trying to conceive on nonpreferred ART regimens (eg, 2-drug regimens like LA CAB and RPV)Optimizing the use of the Antiretroviral Pregnancy RegistryAddressing unique barriers to ARV adherence in transgender individuals with HIV (eg, drug

en

00:22:04

Australian Perspectives on Advances in HIV

Decera Clinical Education Infectious Disease Podcast ·

2023/02/17

In this episode, 2 Australian HIV experts share their thoughts on some of the most important HIV insights gained during the past year in the context of HIV care in Australia.Specifically, the faculty discuss the continued dominance of second-generation INSTI-based regimens as mainstay HIV therapy in Australia, including in both 2-drug and 3-drug oral regimens; the emergence of 2-drug long-acting injectable therapy as a switch strategy; key aspects of successfully expanded oral PrEP programs in the

en

497 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College